NIH “A” Rating for mAbs

Watch Dr. H. Clifford Lane (NIH) and Dr. Raj Gandhi (Harvard) discuss the updated recommendations on the use of monoclonal antibodies released by the NIH COVID-19 Treatment Guidelines Panel in April 2021. Moderated by Ms. Cicely Waters (HHS/ASPR.)

On May 14, 2021, the FDA updated the Emergency Use Authorizations for COVID-19 monoclonal antibodies. These updates expand the definition of “high-risk” patients who are eligible for treatment and provide greater latitude to healthcare providers to exercise their clinical judgment. #CombatCOVID #COVIDTreatments #NIH #HHS #ASPR

For more resources on monoclonal antibody treatment, visit https://go.usa.gov/xHJEG.

For more information, healthcare professionals can visit https://go.usa.gov/xHJEh.

To find out if you or a loved one may be eligible for monoclonal antibody treatment and locate a nearby infusion center, visit https://go.usa.gov/xHJmc.

Тэги:

#Rajesh_Gandhi #H_Clifford_Lane #Cicely_Waters #NIH_COVID-19_Treatment_Guidelines #Department_of_Health_and_Human_Services #Assistant_Secretary_for_Preparedness_and_Response #Combat_COVID #how_to_treat_covid_19 #what_are_treatments_for_covid_19 #treatments_for_covid_19 #what_is_emergency_use_authorization #how_to_treat_covid #emergency_use_authorizations_covid_19 #benefits_of_monoclonal_antibodies #how_to_get_monoclonal_antibody_infusions

Скачать видео